Line 453: |
Line 453: |
| | | | | |
| |- | | |- |
− | | B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan |
| + | |YA |
| | | | | |
| | | | | |
Line 468: |
Line 469: |
| | | | | |
| |- | | |- |
− | | B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease||Ashwini Yenamandra + |
− | | | + | |
| + | Lisa Smith + Yassmine Akkari |
| + | |YA |
| + | |Complete |
| | | | | |
| | | | | |
Line 483: |
Line 487: |
| | | | | |
| |- | | |- |
− | | B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera |
− | | | + | |YA |
| + | |Complete |
| | | | | |
| | | | | |